Thank you for Subscribing to Life Science Review Weekly Brief
Ember's Temperature Control Technology Will Be Expanded for Use in the Healthcare Sector by a New Division.
Fremont, CA: Ember is a global temperature control brand and technology platform on a mission to transform how people eat, drink, and live. Ember, founded by inventor and serial entrepreneur Clay Alexander, creates, builds, and develops temperature control technologies that allow users to customize their temperature completely.
Ember LifeSciences, a new healthcare business spun out of Ember Technologies, was introduced today. The new company will use Ember's proprietary temperature control technologies to provide secure and sustainable cold chain solutions to the healthcare industry.
Earlier this year, Ember launched the Ember Cube, the world's first self-refrigerated, cloud-based shipping box, in collaboration with Cardinal Health, a healthcare distribution company. So Ember's first step into the healthcare arena was with innovation, and the establishment of Ember LifeSciences aims to broaden the brand's goal, specifically within the pharmaceutical business, and harness the power of temperature control to save lives.
"The idea to form Ember LifeSciences started several years ago after meeting with leading companies within the healthcare industry, with a goal to unearth ways in which our temperature control technology could be used to help save lives," said Clay Alexander, Founder and CEO of Ember.
"The Ember Cube is the first of many healthcare technologies developed by our team, and Ember LifeSciences is the entity where all our inventions in the healthcare space will live. With Ember LifeSciences, the goal is to deploy our technology to disrupt the healthcare distribution industry and improve the way we transport temperature-sensitive medicines and vaccines around the world."
Cardinal Health provided an early investment to Ember LifeSciences to develop other cold chain solutions beyond the Ember Cube. Currently, the business is working on two new shipping prototypes: an ultra-low temperature shipper and a cryogenic shipper. Both are designed to transport cell and gene therapy supplies and will feature the same cloud-based temperature monitoring, GPS position tracking, and return-to-sender technologies as the Ember Cube.
Ember LifeSciences has appointed healthcare industry veteran Brian Bejarano as President and General Manager, overseeing all elements of the new company and managing its growth and development. Bejarano joins the team following a 27-year career at Cardinal Health, where he held key roles in strategy, finance, manufacturing, supply chain, and operations, including serving as head of operations for Cardinal Health's Specialty Pharmaceuticals division, which concentrates on cold chain pharmaceuticals such as vaccines, biologics, and cell and gene therapies.